Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study

Burns RM. et al, (2017), Global and Regional Health Technology Assessment

Should the Republic of Ireland introduce a national prostate-specific antigen testing programme for the secondary detection of prostate cancer? Results from a population-based cost-effectiveness analysis

Burns RM. et al, (2017), In: European Journal of Cancer February 2017Volume 72, Supplement 1, Page S117

Machine perfusion in liver transplantation: practical issues to consider in the design and conduct of a complex multinational interventional trial and the potential impact on the analysis

Chiocchia V. et al, (2017), Trials, 18, 200 - 200

Evidence-gathering across industry and academia on early health technology assessment (HTA) of medical devices: Survey design and piloting

Manetti S. et al, (2017), IFMBE Proceedings, 65, 631 - 634

The burden of healthcare costs associated with prostate cancer in Ireland

Burns RM. et al, (2016), Global and Regional Health Technology Assessment, 4, 0 - 0

Economic burden of malignant blood disorders across Europe: a population-based cost analysis.

Burns R. et al, (2016), Lancet Haematol, 3, e362 - e370

Economic burden of non-malignant blood disorders across Europe: a population-based cost study.

Luengo-Fernandez R. et al, (2016), Lancet Haematol, 3, e371 - e378

Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland.

Burns RM. et al, (2014), Value Health, 17, A552 - A553

The Burden of Health Care Costs Associated with Prostate Cancer in Ireland.

Burns RM. et al, (2014), Value Health, 17

Towards Universal Health Care- A Review of the Basic Basket of Care Associated With Universal Health Care Delivery Models.

Burns RM. et al, (2014), Value Health, 17, A417 - A418

Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer.

Bourke S. et al, (2014), J Mark Access Health Policy, 2

Factors driving inequality in prostate cancer survival: a population based study.

Burns RM. et al, (2014), PLoS One, 9

Include forthcoming?